GET THE APP

Proliferative diabetic retinopathy - where are we now? | 56808
Journal of Clinical and Experimental Ophthalmology

Journal of Clinical and Experimental Ophthalmology
Open Access

ISSN: 2155-9570

Proliferative diabetic retinopathy - where are we now?


18th Joint event on European Ophthalmology Congress & Ocular Pharamacology

December 04-06, 2017 | Rome, Italy

Vladislav Dzinic

University Eye Clinic, Serbia
Private Eye Clinic Dzinic, Serbia

Scientific Tracks Abstracts: J Clin Exp Ophthalmol

Abstract :

Diabetic retinopathy is the fifth most common cause of blindness according to new researches. The number of people with moderate to severe visual loss due to DR is constantly growing. Treatment modalities are improving moving the shift from laser photocoagulation to intravitreal injections (anti-VEGF, corticosteroids). Advances in technology of modern vitreoretinal surgical systems, usage of vitreal dyes and smaller gauges (MIVS) allow us to intervene earlier during the disease. Our study presents the results of laser photocoagulation and anti-VEGF treatment approach as well as combined bimanual 4 port pars plana phaco-vitrectomy for advanced proliferative stages and epimacular membranes with or without ILM (inner limiting membrane) removal in the first surgery course. Fifty-three eyes (50 patients) were followed. Visual acuity (VA) ranges from light perception to 0.3. In 18 eyes silicon oil as a tamponade agent was used and removed after 3-6 months after the surgery and in 35 eyes tamponade agent was air. In 29 eyes ILM was peeled primary. In 24 eyes in which ILM was not peeled in the first surgery after 9-12 months epi-macular membrane with significant macular traction was observed in 7 (29.2%) eyes in which additional surgery with ILM peeling was performed. Mean VA at the end of the follow-up period was 0.3 (0.03-0.6) According to our results combined phaco-vitrectomy procedure presents the treatment of choice for patients with severe visual loss, vitreous hemorrhage��?s combined with epimacular membrane and retinal proliferations. Primary peeling of internal limiting membrane ILM has beneficial effect in preventing reoccurrence of epi-macular membrane in diabetic patients. Further investigations are needed to confirm safety and potential damage to the nerve fibre layer to establish ILM peeling as primary procedure.

Biography :

Vladislav Dzinic MD, PhD, DiSSO is an ophthalmologist with interest in anterior-posterior segment surgery and medical retina. He finished his MSc degree in 2008, PhD in 2016. and European school of advance studies in ophthalmology (ESASO) in 2012. He completed fellowships and practice skills at Dr. P N Mahendra Eye Institute and Khairabad Eye Hospital India, University Eye clinic Giessen and Eye Clinical Center of the University of Tubingen, Germany. He is a member of EVRS, EURETINA and ESCRS.  He is currently working at University Eye clinic Novi Sad and Private Eye center Dzinic.
 

Top